TMO
Thermo Fisher Scientific Inc
Healthcare · in the S&P 500
📍 Waltham, United States · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
10 years from the annual reports
Source: SEC filings (10-K) ↗Revenue and profit
Revenue was $44.6bn in FY2025, against $18.3bn in FY2016. Net profit was $6.7bn — 15 of every 100 of revenue.
Cash the business generated
In FY2025, operations brought in $7.8bn; after $1.5bn spent on property and equipment, $6.3bn was left (free cash flow).
Debt and cash at year end
At the end of FY2025 the company reported $39.2bn of long-term debt and $9.9bn of cash and equivalents.
As reported in each year's 10-K, in US dollars. Companies label some items differently, and a year can be missing where a figure wasn't reported in a comparable way.
Key figures, against the S&P 500
Figures as of 9 Nov 2026, refreshed weekly
Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
36.9x
The share price is 36.9 times the last twelve months' earnings per share.
P/E on average earnings?
39.9x
The share price is 39.9 times earnings per share averaged over recent years.
Price / book
4.7x
The market values the company at 4.7 times the accounting value of its equity.
EV / EBIT?
33.6x
The company's value including its debt is 33.6 times its operating profit.
Free cash flow yield?
2.5%
Free cash flow equals 2.5% of the company's market value.
Profitability
Return on equity?
13.4%
Each 100 of shareholders' money produced 13.4 of net profit.
Return on assets?
5.2%
Each 100 of assets produced 5.2 of net profit.
Return on invested capital
8.7%
Each 100 invested by lenders and owners produced 8.7 of profit.
Operating margin?
19.6%
Of every 100 in sales, 19.6 was left as operating profit.
Debt
Debt / equity?
75.4%
Total debt equals 75% of shareholders' equity.
Net debt / EBITDA?
2.9x
Net debt equals 2.9 years of operating earnings (EBITDA).
Interest cover
6.2x
Operating profit was 6.2 times the interest bill.
Growth
Revenue growth
2.3%
Latest revenue is 2.3% above the average of earlier reported years.
Earnings growth
4.3%
Latest net profit is 4.3% above the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.